Patients with heart failure with improved ejection fraction benefit from the SGLT2 inhibitor dapagliflozin: Study
With modern therapies for heart failure (HF) with reduced ejection fraction (HFrEF), some patients can improve their cardiac function during treatment. But despite this improvement in the ability of their hearts to pump, ...
Dec 15, 2022
0
8